Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Cosimo De Nunzio, Benjamin Brucker, Thomas Bschleipfer, et al. Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men. Eur Urol 2021;79:492-504

Affiliations

• ¹ Urology Unit, Ospedale Sant'Andrea, Sapienza University of Rome, Rome, Italy. Electronic address: cosimodenunzio@virgilio.it.
• ² New York University Langone Health, New York, NY, USA.
• ³ Clinic for Urology, Andrology and Pediatric Urology, Clinics of Nordoberpfalz AG, Weiden, Germany.
• ⁴ Urology Department, Charles Nicolle University Hospital, University of Rouen, Rouen, France.
• ⁵ Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.
• ⁶ Urology Unit, University of Campania L. Vanvitelli, Naples, Italy.
• ⁷ Department of Urology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
• ⁸ Department of Urology, Pediatric Urology & Urological Oncology, St. Antonius Hospital, Gronau, Germany.
• ⁹ Department of Urology, University of Rennes, Rennes, France.
• ¹⁰ Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
• ¹¹ Department of Urology, Maastricht University Medical Center, Maastricht, The Netherlands.
• ¹² Department of Urology, Clinic Favoriten and Sigmund Freud Private University, Vienna, Austria.